8th International Conference on

Vaccines Research & Development

International Conference on Vaccines Research & Development is a federally registered trademark (reg.no. 5226683) owned by USG United Scientific Group (A non-profit organization). Beware of fraudulent conferences mimicking the Official Vaccines R&D Conference.

Bronze Sponsor :

img-responsive
image

A Glimpse of Vaccines R&D 2022 Boston

Vaccines R&D 2023

Companies Represented at Vaccines R&D 2022

Since 2015, Vaccines R&D meeting continue to attract active participants including top executives from companies, clinicians, academicians, federal researchers, policymakers and other high-level decision-makers. With this varied kind of participation come plenty of opportunities to seek out funding for new research, get quality feedback before publishing your research, collaborations, and new jobs.

image
Conference Topics
  • Approaches for vaccine development
  • Bacterial and Viral
  • RSV, influenza
  • Cancer, HIV
  • Emerging diseases
  • Manufacturing and regulatory
  • Role of adjuvants
  • Vaccine safety
  • Conjugate vaccines
  • Vaccine process development & production
  • Clinical trials
  • Technology & delivery platforms
  • COVID-19
  • Novel assays
  • Immune characterization

2023 Speakers

Peter Marks

Peter Marks, M.D., Ph.D.

Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)
Diane E. Griffin

Diane E. Griffin, M.D., Ph.D.

Vice President, National Academy of Sciences, University Distinguished Service Professor, Johns Hopkins Bloomberg School of Public Health
Karin Bok

Karin Bok, M.S., Ph.D.

Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH
Ofer Levy

Ofer Levy, M.D., Ph.D.

Director, Precision Vaccines Program; Senior Physician in Infectious Diseases, Boston Children's Hospital; Professor, Harvard Medical School
Mark Emalfarb

Mark Emalfarb, Ph.D.

Chief Executive Officer,
Dyadic International, Inc.
Jacqueline Miller

Jacqueline Miller, M.D.

Senior Vice President, Head of Development, Infectious Diseases, Moderna
Amy Finan

Amy Finan

Chief Executive Officer,
Sabin Vaccine Institute
Tonya Villafana

Tonya Villafana, Ph.D.

Vice President, Global Franchise Head, Infection, AstraZeneca

00

Year of Foundation

00

Speakers

00

Attendees

00

Happy Clients

Registration Plans

Late Registration ends 27th October! Save up to $200

Academics & Researchers

$1049
  • Access to all talks and posters
  • Conference material
  • Hot buffet lunch, tea / coffee breaks
  • WiFi in meeting rooms
  • Networking and drinks

Federal

$1299
  • Access to all talks and posters
  • Conference material
  • Hot buffet lunch, tea / coffee breaks
  • WiFi in meeting rooms
  • Networking and drinks

Biotech & Pharma

$1499
  • Access to all talks and posters
  • Conference material
  • Hot buffet lunch, tea / coffee breaks
  • WiFi in meeting rooms
  • Networking and drinks

Service Providers

$1599
  • Access to all talks and posters
  • Conference material
  • Hot buffet lunch, tea / coffee breaks
  • WiFi in meeting rooms
  • Networking and drinks

2022 Sponsors & Exhibitors

Sponship Guide
image
image
image
image

Testimonials

Vaccines R&D Previous Events